Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1459162
This article is part of the Research Topic Opportunistic pathogens: pathogenesis and multi-drug resistance mechanisms View all 6 articles

Distribution diversity and expression regulation of class 1 integron promoters in clinical isolates of Morganella morganii

Provisionally accepted
Ye Yang Ye Yang 1Hui Zhang Hui Zhang 2*Rongqing Zhao Rongqing Zhao 1*Xuedan Qiu Xuedan Qiu 1Jinglu Ye Jinglu Ye 1*Wenjun Lu Wenjun Lu 1*Qingcao Li Qingcao Li 1*Guangliang Wu Guangliang Wu 1*
  • 1 The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
  • 2 Ninghai County Chengguan Hospital, Ningbo, China

The final, formatted version of the article will be published soon.

    Background: Morganella morganii is an emerging nosocomial opportunistic pathogen with increasing multidrug resistance. Antibiotic resistance, driven primarily by the horizontal transfer of resistance genes, has become a global health crisis. Integrons, mobile genetic elements, are now understood to facilitate the transfer of these genes, contributing to the rapid proliferation of resistant strains. Understanding the regulatory role of integrons in drug resistance gene expression is crucial for developing novel strategies to combat this pressing public health issue.Objective: To investigate the distribution of promoter types in the variable regions of class 1 integrons isolated from clinical isolates of M. morganii and their regulatory role in the expression of downstream drug resistance gene cassettes.Methods: 97 clinical isolates of M. morganii were screened for the presence of class 1 integrons (intI1) using polymerase chain reaction (PCR). Gene cassettes within the variable regions of positive isolates were characterized, and the gene cassette promoter Pc variants and downstream auxiliary promoter P2 were identified. Enterobacterial repetitive intergenic consensus (ERIC)-PCR was employed for homology analysis. Recombinant plasmids containing different variable region promoters and gene cassettes were constructed to evaluate drug resistance genes and integrase (intI1) expression levels using reverse transcription-quantitative PCR (RT-qPCR) and antimicrobial susceptibility testing. Results: Of the clinical isolates, 28.9% (n=28/97) were positive for class 1 integrons. 24.7% (n=24/97) of these isolates carried gene cassettes encoding resistance to aminoglycosides and trimethoprim. Three Pc promoter types (PcH1, PcS, and PcW) were identified, while all P2 promoters were inactive with a 14-base pair spacing between the -35 and -10 regions. ERIC-PCR analysis classified the integronpositive strains into 6 genotypes, with high consistency in promoter types and gene cassettes within each genotype. RT-qPCR and antimicrobial susceptibility testing demonstrated that strong promoters significantly enhanced the expression of downstream drug resistance gene cassettes compared to weak promoters. Additionally, RT-qPCR revealed a negative correlation between intI1 expression and Pc promoter strength.Class 1 integrons are prevalent in M. morganii. The promoter types within these integrons are diverse, and promoter strength is closely linked to downstream gene cassette expression. Integronpositive strains exhibit high homology, suggesting horizontal gene transfer and dissemination in clinical settings.

    Keywords: Morganella morganii, integron, Promoter, expression regulation, homology

    Received: 03 Jul 2024; Accepted: 09 Oct 2024.

    Copyright: © 2024 Yang, Zhang, Zhao, Qiu, Ye, Lu, Li and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Hui Zhang, Ninghai County Chengguan Hospital, Ningbo, China
    Rongqing Zhao, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
    Jinglu Ye, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
    Wenjun Lu, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
    Qingcao Li, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China
    Guangliang Wu, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.